vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $287.8M, roughly 1.7× QUINSTREET, INC). QUINSTREET, INC runs the higher net margin — 17.4% vs 6.8%, a 10.6% gap on every dollar of revenue. On growth, QUINSTREET, INC posted the faster year-over-year revenue change (1.9% vs -1.7%). Over the past eight quarters, QUINSTREET, INC's revenue compounded faster (53.2% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.

MD vs QNST — Head-to-Head

Bigger by revenue
MD
MD
1.7× larger
MD
$493.8M
$287.8M
QNST
Growing faster (revenue YoY)
QNST
QNST
+3.6% gap
QNST
1.9%
-1.7%
MD
Higher net margin
QNST
QNST
10.6% more per $
QNST
17.4%
6.8%
MD
Faster 2-yr revenue CAGR
QNST
QNST
Annualised
QNST
53.2%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
MD
MD
QNST
QNST
Revenue
$493.8M
$287.8M
Net Profit
$33.7M
$50.2M
Gross Margin
9.6%
Operating Margin
9.9%
0.4%
Net Margin
6.8%
17.4%
Revenue YoY
-1.7%
1.9%
Net Profit YoY
10.5%
3342.5%
EPS (diluted)
$0.40
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
QNST
QNST
Q4 25
$493.8M
$287.8M
Q3 25
$492.9M
$285.9M
Q2 25
$468.8M
Q1 25
$458.4M
$269.8M
Q4 24
$502.4M
$282.6M
Q3 24
$511.2M
$279.2M
Q2 24
$504.3M
$198.3M
Q1 24
$495.1M
$168.6M
Net Profit
MD
MD
QNST
QNST
Q4 25
$33.7M
$50.2M
Q3 25
$71.7M
$4.5M
Q2 25
$39.3M
Q1 25
$20.7M
$4.4M
Q4 24
$30.5M
$-1.5M
Q3 24
$19.4M
$-1.4M
Q2 24
$-153.0M
$-2.2M
Q1 24
$4.0M
$-7.0M
Gross Margin
MD
MD
QNST
QNST
Q4 25
9.6%
Q3 25
9.4%
Q2 25
Q1 25
10.3%
Q4 24
9.5%
Q3 24
10.2%
Q2 24
8.8%
Q1 24
8.5%
Operating Margin
MD
MD
QNST
QNST
Q4 25
9.9%
0.4%
Q3 25
13.8%
1.7%
Q2 25
12.8%
Q1 25
7.0%
1.8%
Q4 24
7.8%
-0.5%
Q3 24
6.6%
-0.4%
Q2 24
-31.3%
-0.7%
Q1 24
3.2%
-3.2%
Net Margin
MD
MD
QNST
QNST
Q4 25
6.8%
17.4%
Q3 25
14.5%
1.6%
Q2 25
8.4%
Q1 25
4.5%
1.6%
Q4 24
6.1%
-0.5%
Q3 24
3.8%
-0.5%
Q2 24
-30.3%
-1.1%
Q1 24
0.8%
-4.2%
EPS (diluted)
MD
MD
QNST
QNST
Q4 25
$0.40
$0.87
Q3 25
$0.84
$0.08
Q2 25
$0.46
Q1 25
$0.24
$0.08
Q4 24
$0.37
$-0.03
Q3 24
$0.23
$-0.02
Q2 24
$-1.84
$-0.04
Q1 24
$0.05
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
QNST
QNST
Cash + ST InvestmentsLiquidity on hand
$375.2M
$107.0M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$294.4M
Total Assets
$2.2B
$493.0M
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
QNST
QNST
Q4 25
$375.2M
$107.0M
Q3 25
$340.1M
$101.3M
Q2 25
$224.7M
Q1 25
$99.0M
$81.8M
Q4 24
$229.9M
$57.8M
Q3 24
$103.8M
$25.0M
Q2 24
$19.4M
$50.5M
Q1 24
$8.0M
$39.6M
Total Debt
MD
MD
QNST
QNST
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
QNST
QNST
Q4 25
$865.9M
$294.4M
Q3 25
$890.7M
$246.7M
Q2 25
$833.8M
Q1 25
$789.2M
$235.5M
Q4 24
$764.9M
$224.3M
Q3 24
$732.5M
$219.8M
Q2 24
$706.5M
$216.8M
Q1 24
$856.2M
$215.0M
Total Assets
MD
MD
QNST
QNST
Q4 25
$2.2B
$493.0M
Q3 25
$2.2B
$442.6M
Q2 25
$2.1B
Q1 25
$2.0B
$417.2M
Q4 24
$2.2B
$409.6M
Q3 24
$2.1B
$401.2M
Q2 24
$2.0B
$368.5M
Q1 24
$2.2B
$349.3M
Debt / Equity
MD
MD
QNST
QNST
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
QNST
QNST
Operating Cash FlowLast quarter
$114.1M
$21.6M
Free Cash FlowOCF − Capex
$20.7M
FCF MarginFCF / Revenue
7.2%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
3.39×
0.43×
TTM Free Cash FlowTrailing 4 quarters
$106.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
QNST
QNST
Q4 25
$114.1M
$21.6M
Q3 25
$137.3M
$19.6M
Q2 25
$137.2M
Q1 25
$-117.5M
$30.1M
Q4 24
$133.0M
$38.7M
Q3 24
$91.8M
$-13.7M
Q2 24
$107.0M
$16.6M
Q1 24
$-125.2M
$4.1M
Free Cash Flow
MD
MD
QNST
QNST
Q4 25
$20.7M
Q3 25
$18.4M
Q2 25
Q1 25
$29.5M
Q4 24
$38.2M
Q3 24
$-14.1M
Q2 24
$15.4M
Q1 24
$2.9M
FCF Margin
MD
MD
QNST
QNST
Q4 25
7.2%
Q3 25
6.4%
Q2 25
Q1 25
10.9%
Q4 24
13.5%
Q3 24
-5.1%
Q2 24
7.8%
Q1 24
1.7%
Capex Intensity
MD
MD
QNST
QNST
Q4 25
0.3%
Q3 25
0.4%
Q2 25
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.2%
Q2 24
0.6%
Q1 24
0.7%
Cash Conversion
MD
MD
QNST
QNST
Q4 25
3.39×
0.43×
Q3 25
1.91×
4.32×
Q2 25
3.49×
Q1 25
-5.66×
6.82×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

QNST
QNST

Financial Service$216.8M75%
Home Services And Other Revenue$71.0M25%

Related Comparisons